Literature DB >> 8590984

Ketanserin-sensitive depressant actions of 5-HT receptor agonists in the neonatal rat spinal cord.

N A Manuel1, D I Wallis, H Crick.   

Abstract

1. The monosynaptic reflex (MSR), recorded in vitro from the neonatal rat spinal cord, was depressed by 5-hydroxytryptamine (5-HT), 5-carboxamidotryptamine (5-CT), methysergide and R(+)-8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), and also by the selective 5-HT1D agonists, sumatriptan and N-methyl-3-(1-methyl-1-piperidinyl)-1H-indole-5-ethane sulphonamide (GR 85548). 2. Ketanserin (1 microM) and methiothepin (1 microM) reduced the duration of depressions elicited by 5-CT, but not those produced by 5-HT, sumatriptan, GR 85548, methysergide or 8-OH-DPAT. 3. The IC50 for MSR depression by 5-CT was 3.6, 2.1-6.2 nM (n = 4), by sumatriptan was 15.2, 12.9-18.0 nM (n = 32), by GR 85548 was 18.4, 11.7-29.1 nM (n = 12), by methysergide was 29.8, 10.2-87.1 nM (n = 4) and by 8-OH-DPAT was 0.21, 0.11-0.43 microM (n = 3) (geometric means and 95% confidence limits). 4. Ketanserin (0.1 or 1 microM) antagonized competitively responses to sumatriptan (apparent pA2 7.8 +/- 0.1, n = 5), GR 85548 (apparent pA2 7.6, unpaired data, n = 5), methysergide (apparent pA2 7.9 +/- 0.12, n = 4) and 8-OH-DPAT (apparent pA2 8.3 +/- 0.1, n = 3). Concentration-response curves to 5-CT showed a smaller, parallel shift to the right (apparent pA2 6.8 +/- 0.1, n = 4), but responses to 5-HT were unaffected by ketanserin (1 microM) (n = 4). 5. Methiothepin (1 microM) antagonized competitively responses to GR 85548 (apparent pA2 7.7, unpaired data, n = 5). 6. Mianserin (0.3 microM), a concentration sufficient to cause substantial block of 5-HT2C-mediated responses but have only a small effect on 5-HT1D-mediated actions, caused a small, non-parallel shift of the concentration-response curve to sumatriptan. 7. Depression of the MSR by sumatriptan was not blocked by (+/-)-cyanopindolol (0.1 microM), (+/-)-propranolol (0.5 or 1 microM) or spiroxatrine (0.1 microM), and depression of MSR by 8-OH-DPAT was not blocked by spiroxatrine (0.1 microM). (+/-)-Cyanopindolol (0.1 and 1 microM) itself induced a slow depression of the MSR. 8. The novel 5-HT1D antagonist, N-[4-methyl-1-piperazinyl) phenyl]2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl) [1,1-biphenyl]-4-carboxamide (GR 127935, 30 nM to 1 microM) caused a concentration-related depression of the reflex (up to 50%) usually slow in onset. Neither with these concentrations nor with concentrations in the range 1-3 nM was there any unequivocal blockade of responses to sumatriptan. 9. It is concluded that sumatriptan, GR 85548, methysergide and 8-OH-DPAT depress the MSR in the neonate rat spinal cord via ketanserin-sensitive receptors, which have some similarities to 5-HT1D alpha receptors but which are not blocked by GR 127935. 5-HT released by tryptaminergic pathways may act via the same receptors to depress the MSR. 5-HT applied to the cord probably acts via a different, possibly novel 5-HT receptor to depress the MSR.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8590984      PMCID: PMC1909148          DOI: 10.1111/j.1476-5381.1995.tb17221.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

Review 1.  Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain.

Authors:  D Hoyer; D N Middlemiss
Journal:  Trends Pharmacol Sci       Date:  1989-04       Impact factor: 14.819

Review 2.  5-HT receptors: subtypes and second messengers.

Authors:  D Hoyer; P Schoeffter
Journal:  J Recept Res       Date:  1991

3.  Serotonin via presynaptic 5-HT1 receptors attenuates synaptic transmission to immature rat motoneurons in vitro.

Authors:  S Y Wu; M Y Wang; N J Dun
Journal:  Brain Res       Date:  1991-07-19       Impact factor: 3.252

4.  5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery.

Authors:  A A Parsons; E T Whalley; W Feniuk; H E Connor; P P Humphrey
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

5.  5-Hydroxytryptamine responses in neonate rat motoneurones in vitro.

Authors:  M Y Wang; N J Dun
Journal:  J Physiol       Date:  1990-11       Impact factor: 5.182

Review 6.  The concept of selectivity in 5-HT receptor research.

Authors:  I van Wijngaarden; M T Tulp; W Soudijn
Journal:  Eur J Pharmacol       Date:  1990-06-12       Impact factor: 4.432

7.  Receptor subtypes mediating facilitation by serotonin of excitability of spinal motoneurons.

Authors:  D A Jackson; S R White
Journal:  Neuropharmacology       Date:  1990-09       Impact factor: 5.250

8.  Inhibition of reflex responses of neonate rat lumbar spinal cord by 5-hydroxytryptamine.

Authors:  H Crick; D I Wallis
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

9.  Further studies on the action of 5-hydroxytryptamine on lumbar motoneurones in the rat isolated spinal cord.

Authors:  D I Wallis; L A Connell; Z Kvaltinova
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-04       Impact factor: 3.000

10.  Evidence that 5-hydroxytryptamine release in rat dorsal raphé nucleus is controlled by 5-HT1A, 5-HT1B and 5-HT1D autoreceptors.

Authors:  C Davidson; J A Stamford
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

View more
  6 in total

1.  Pharmacological characterization of serotonin receptor subtypes modulating primary afferent input to deep dorsal horn neurons in the neonatal rat.

Authors:  S M Garraway; S Hochman
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

Review 2.  Serotonergic transmission after spinal cord injury.

Authors:  Raffaele Nardone; Yvonne Höller; Aljoscha Thomschewski; Peter Höller; Piergiorgio Lochner; Stefan Golaszewski; Francesco Brigo; Eugen Trinka
Journal:  J Neural Transm (Vienna)       Date:  2014-05-28       Impact factor: 3.575

3.  Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.

Authors:  J M Zgombick; L E Schechter; N Adham; S A Kucharewicz; R L Weinshank; T A Branchek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

4.  Polysynaptic excitatory postsynaptic potentials that trigger spasms after spinal cord injury in rats are inhibited by 5-HT1B and 5-HT1F receptors.

Authors:  Katherine C Murray; Marilee J Stephens; Michelle Rank; Jessica D'Amico; Monica A Gorassini; David J Bennett
Journal:  J Neurophysiol       Date:  2011-06-08       Impact factor: 2.714

5.  Reduction of spinal sensory transmission by facilitation of 5-HT1B/D receptors in noninjured and spinal cord-injured humans.

Authors:  Jessica M D'Amico; Yaqing Li; David J Bennett; Monica A Gorassini
Journal:  J Neurophysiol       Date:  2012-12-05       Impact factor: 2.714

6.  Serotonin-induced inhibition of locomotor rhythm of the rat isolated spinal cord is mediated by the 5-HT1 receptor class.

Authors:  M Beato; A Nistri
Journal:  Proc Biol Sci       Date:  1998-11-07       Impact factor: 5.349

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.